Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Net Income | -397.21% | 83.28% | 88.25% | -2,925.62% | 54.49% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -194.59% | -- | -- | 9,620.89% | -- |
| Change in Net Operating Assets | 128.66% | -575.12% | -89.88% | 256.01% | 160.62% |
| Cash from Operations | -126.18% | 61.65% | -55.84% | -1,057.92% | 93.99% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -201.77% | 111.92% | 42.79% | -114.92% | 48.43% |
| Cash from Investing | -201.77% | 111.92% | -89.60% | 35.15% | 56.90% |
| Total Debt Issued | -- | -200.00% | -99.64% | 1,827.98% | -52.56% |
| Total Debt Repaid | 265.14% | 121.50% | -1,742.86% | -- | -- |
| Issuance of Common Stock | -29.01% | -93.31% | -- | -- | -40.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 399.39% | 111.87% | -439.21% | 193.12% | -174.04% |
| Cash from Financing | 157.88% | -72.08% | 76.04% | 116.07% | -76.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,066.67% | -200.00% | 99.57% | -199.57% | 23,200.00% |
